These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 11724325

  • 1. Synergistic enhancement of apoptosis by DNA- and cytoskeleton-damaging agents: a basis for combination chemotherapy of cancer.
    Shang X, Shiono Y, Fujita Y, Oka S, Yamazaki Y.
    Anticancer Res; 2001; 21(4A):2585-9. PubMed ID: 11724325
    [Abstract] [Full Text] [Related]

  • 2. Cytoskeletal disruption accelerates caspase-3 activation and alters the intracellular membrane reorganization in DNA damage-induced apoptosis.
    Yamazaki Y, Tsuruga M, Zhou D, Fujita Y, Shang X, Dang Y, Kawasaki K, Oka S.
    Exp Cell Res; 2000 Aug 25; 259(1):64-78. PubMed ID: 10942579
    [Abstract] [Full Text] [Related]

  • 3. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Singh TR, Shankar S, Chen X, Asim M, Srivastava RK.
    Cancer Res; 2003 Sep 01; 63(17):5390-400. PubMed ID: 14500373
    [Abstract] [Full Text] [Related]

  • 4. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
    Mikami T, Koyama T, Koyama T, Imakiire A, Yamamoto K, Furuhata M, Toyota H, Mizuguchi J.
    Anticancer Res; 2006 Sep 01; 26(2A):1153-60. PubMed ID: 16619517
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
    Yamamoto-Yamaguchi Y, Okabe-Kado J, Kasukabe T, Honma Y.
    Anticancer Res; 2003 Sep 01; 23(3B):2537-47. PubMed ID: 12894538
    [Abstract] [Full Text] [Related]

  • 9. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
    Furlong SJ, Ridgway ND, Hoskin DW.
    Int J Oncol; 2008 Mar 01; 32(3):537-44. PubMed ID: 18292930
    [Abstract] [Full Text] [Related]

  • 10. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S.
    Cancer Res; 2003 Feb 01; 63(3):621-6. PubMed ID: 12566305
    [Abstract] [Full Text] [Related]

  • 11. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH, Cory JG.
    Anticancer Res; 2002 Feb 01; 22(6C):3805-9. PubMed ID: 12552998
    [Abstract] [Full Text] [Related]

  • 12. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
    Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A, Schmoll HJ.
    Cancer Res; 2003 Jan 15; 63(2):513-21. PubMed ID: 12543810
    [Abstract] [Full Text] [Related]

  • 13. In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.
    Gupta A, Le A, Belinka BA, Kachlany SC.
    Leuk Res; 2011 Nov 15; 35(11):1498-505. PubMed ID: 21664691
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. ATPase inhibitors suppress actinomycin D-induced apoptosis in leukemia cells.
    Shiono Y, Fujita Y, Oka S, Yamazaki Y.
    Anticancer Res; 2002 Nov 15; 22(5):2907-11. PubMed ID: 12530016
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A comparative study on the anti-angiogenic effects of DNA-damaging and cytoskeletal-disrupting agents.
    Mabeta P, Pepper MS.
    Angiogenesis; 2009 Nov 15; 12(1):81-90. PubMed ID: 19214765
    [Abstract] [Full Text] [Related]

  • 20. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
    Crawford KW, Bowen WD.
    Cancer Res; 2002 Jan 01; 62(1):313-22. PubMed ID: 11782394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.